The Global Fund Board has approved Phase 2 funding for a Round 9 HIV grant in Bosnia and Hercegovina in the amount of $13.5 million. The principal recipient (PR) for the grant is the United Nations Development Programme (UNDP). UNDP is also PR for another HIV grant, which has been essentially completed, and for a TB grant in Bosnia and Hercegovina.
Aidspan has published a paper critiquing the way in which the Global Fund quantifies lives saved through programmes that it supports. The paper was prepared by Dr David McCoy, a public health physician and senior clinical lecturer at Queen Mary University London, and Nele Jensen, a physician.
The Global Fund has released its results report for 2012, entitled “Strategic Investments for Impact.” The 94-page report provides comprehensive information on the achievements of programmes supported by the Global Fund through June 2012, and discusses some of the strategic issues the Fund is currently addressing.
The government of Peru has taken up funding for many activities that were initiated with Global Fund support over the past eight years and has achieved considerable success in the fight against the three diseases. This was one of the conclusions of a diagnostic review of Global Fund grants to Peru conducted by the Office of Inspector General.
A new publication from Aidspan, by Dr David McCoy, reviews a published academic study on the impact of Global Fund grants for malaria prevention.
As of June 2010, 5.7 million lives have been saved as a result of programmes supported by the Global Fund, according to estimates recently released by the Fund. The Global Fund calculates that this means that another 4,000 deaths are averted every day.
Every day, programmes supported by the Global Fund save at least 3,600 lives, and there has been a dramatic increase in the volume of services delivered. These are two of the highlights of "The Global Fund 2010: Innovation and Impact," a report on results achieved which was released by the Global Fund on 8 March 2010.
Mother-to-child HIV transmission may be eliminated by 2015; malaria may be eliminated as a public health problem within a decade; TB prevalence could be halved by 2015. However, these health targets can only be achieved if current rates of scaling up expenditure on the three diseases are maintained and, ideally, further accelerated.